Subsequent Events (Details) - Subsequent event - R-Bridge Financing - China $ in Millions |
Mar. 29, 2022
USD ($)
|
---|---|
Subsequent Event | |
Upfront payment | $ 15.0 |
Milestone payment upon first commercial sale in China | 15.0 |
Commercialization milestone payments | $ 10.0 |
Jiangsu Nhwa Pharmaceutical Co Ltd | |
Subsequent Event | |
Net revenue interest in U.S. net sales (as a percent) | 4.00% |
Cap of U.S. revenue interest if Chinese approval occurs by year-end 2023 | $ 10.0 |
Net revenue interest in U.S. net sales if approval target is not reached (as a percent) | 7.00% |
Milestone payment upon regulatory approval in China | $ 3.0 |
X | ||||||||||
- Definition Represents the amount of milestone payment to be received upon regulatory approval under collaborative arrangement. No definition available.
|
X | ||||||||||
- Definition Represents the amount of milestone payment to be received upon foreign regulatory approval under collaborative arrangement. No definition available.
|
X | ||||||||||
- Definition Represents the amount of upfront payment to be received upon the first foreign commercial sale. No definition available.
|
X | ||||||||||
- Definition Represents the collaborative arrangement revenue interest cap if foreign approval occurs by second fiscal year after the current fiscal year. No definition available.
|
X | ||||||||||
- Definition Represents the amount of upfront payment to be received under collaborative arrangement. No definition available.
|
X | ||||||||||
- Definition Percentage of net revenue interest in U.S. net sales. No definition available.
|
X | ||||||||||
- Definition Percentage of net revenue interest in U.S. net sales if approval target is not reached. No definition available.
|
X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|